Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lexaria Bioscience Corp. Director's Dealing 2009

Jun 15, 2009

34983_dirs_2009-06-15_ff5eb2f2-3634-4635-b038-5943f5ab520e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRA)
CIK: 0001348362
Period of Report: 2009-06-11

Reporting Person: BUNKA CHRISTOPHER (Director, Chairman/CEO/President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-06-11 Common Shares P 25900 $0.04 Acquired 1390350 Indirect
2009-06-11 Common Shares P 162500 $0.01 Acquired 1552850 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 863600 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants $0.6 2009-11-09 Common Shares (1116800) 1116800 Indirect
Stock Options $0.8 2011-04-26 Stock Options (400000) 400000 Direct
Stock Options $0.12 2011-07-20 Common Shares (400000) 400000 Direct

Footnotes

F1: Chris Bunk is tyhe sole owner of CAB Financial Services Ltd.

F2: On June 19, 2007, the exercise price was reduced from $1.30